Parkinson’s disease (PD) is a progressive neurological disorder that affects millions of people around the world. It is characterized by motor symptoms such as tremors, stiffness, and difficulty with balance and coordination. While these motor symptoms are the most visible signs of PD, the disease also causes a range of non-motor symptoms that are often invisible and can be difficult to recognize. This article will explore the unseen struggles of PD and provide an understanding of the various non-motor symptoms associated with the disease.
PD is a chronic, progressive neurological disorder caused by the death of dopamine-producing neurons in the brain. This leads to a decrease in the amount of dopamine available to the brain, resulting in the motor symptoms of PD. The most common motor symptoms include tremors, slowness of movement, stiffness, and difficulty with balance and coordination.
In addition to the motor symptoms of PD, the disease also causes a range of non-motor symptoms. These can include cognitive and behavioral changes, sleep disturbances, and mood changes.
PD can cause changes in thinking, memory, and behavior. Cognitive changes can include difficulty with problem solving, memory problems, and difficulty with multitasking. Behavioral changes can include apathy, impulsivity, and disinhibition.
PD can cause a range of sleep disturbances, including insomnia, excessive daytime sleepiness, and rapid eye movement (REM) sleep behavior disorder. Insomnia can be caused by the motor symptoms of PD, such as tremors, stiffness, and difficulty with balance and coordination, which can make it difficult to fall asleep and stay asleep. Excessive daytime sleepiness can be caused by sleep apnea, a condition in which the person stops breathing during sleep. REM sleep behavior disorder is a condition in which the person acts out their dreams while sleeping, which can lead to disruptive and dangerous behaviors.
PD can also cause changes in mood, including depression and anxiety. Depression is one of the most common non-motor symptoms of PD, and can be caused by a combination of physical and psychological factors. Anxiety can be caused by the uncertainty of living with a chronic, progressive disease, as well as the fear of developing motor symptoms.
Non-motor symptoms of PD can be managed with medications, lifestyle changes, and psychotherapy. Medications can be used to manage cognitive and behavioral changes, sleep disturbances, and mood changes. Lifestyle changes, such as exercise and stress management, can also help to manage the non-motor symptoms of PD. Psychotherapy can help to manage the psychological aspects of the disease, such as depression and anxiety.
PD is a progressive neurological disorder that affects millions of people around the world. While the motor symptoms of PD are the most visible signs of the disease, it also causes a range of non-motor symptoms that can be difficult to recognize. These non-motor symptoms can include cognitive and behavioral changes, sleep disturbances, and mood changes. Non-motor symptoms of PD can be managed with medications, lifestyle changes, and psychotherapy. Understanding the unseen struggles of PD can help to provide a better understanding of the disease and how to manage its symptoms.
1.
Two medications might work better for breast cancers that are resistant to one.
2.
Can Oncotype Predict Recurrence Risk in Older BC Patients?
3.
Surgeons are at higher risk of cancer, study suggests
4.
Kidney cancer: Understanding what a renal cell carcinoma diagnosis means
5.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
1.
Demystifying Lymphocytes: Everything You Need to Know
2.
The Role of Alanine Aminotransferase in Liver Health and Disease
3.
The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery
4.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
5.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation